Ratings changes for Astera Labs, Super Micro Computer, Advanced Micro Devices, Rivian Automotive, Advanced Micro Devices, Advanced Energy Industries, Advanced Micro Devices and more…Text “MarketBeat” to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Investing Legend Hints the End May be Near for These 3 Iconic Stocks
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he’s sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new “Sell This, Buy That” broadcast.
CEO Douglas J. Herrington sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $217.00, for a total value of $542,500.00. Following the completion of the transaction, the chief executive officer directly owned 512,050 shares of the company’s stock, valued at $111,114,850. This trade represents a 0.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Archer Daniels Midland (NYSE:ADM) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $61.00 price target on the stock, up previously from $50.00. This represents a 5.0% upside from the current price of $58.12.
Digital Turbine (NASDAQ:APPS) was upgraded by analysts at Bank of America Corporation from an “underperform” rating to a “neutral” rating. They now have a $5.50 price target on the stock, up previously from $4.50. This represents a 21.5% upside from the current price of $4.53.
Aramark (NYSE:ARMK) was upgraded by analysts at Robert W. Baird from a “neutral” rating to an “outperform” rating. They now have a $47.00 price target on the stock, up previously from $43.00. This represents a 17.6% upside from the current price of $39.96.
A10 Networks (NYSE:ATEN) was upgraded by analysts at BTIG Research from a “neutral” rating to a “buy” rating. They now have a $22.00 price target on the stock. This represents a 13.6% upside from the current price of $19.37.
Azenta (NASDAQ:AZTA) was upgraded by analysts at Raymond James Financial, Inc. from a “market perform” rating to an “outperform” rating. They now have a $35.00 price target on the stock. This represents a 19.2% upside from the current price of $29.37.
BellRing Brands (NYSE:BRBR) was upgraded by analysts at Stephens from an “equal weight” rating to an “overweight” rating. They now have a $50.00 price target on the stock. This represents a 32.8% upside from the current price of $37.65.
Camden National (NASDAQ:CAC) was upgraded by analysts at Stephens from an “equal weight” rating to an “overweight” rating. They now have a $44.00 price target on the stock. This represents a 18.5% upside from the current price of $37.12.
Comerica (NYSE:CMA) was upgraded by analysts at Jefferies Financial Group Inc. from an “underperform” rating to a “hold” rating. They now have a $70.00 price target on the stock, up previously from $50.00. This represents a 3.0% upside from the current price of $67.97.
Coupang (NYSE:CPNG) was upgraded by analysts at Nomura from a “neutral” rating to a “buy” rating. They now have a $35.00 price target on the stock. This represents a 26.6% upside from the current price of $27.65.
CryoPort (NASDAQ:CYRX) was upgraded by analysts at Leerink Partners from a “market perform” rating to an “outperform” rating. They now have a $16.00 price target on the stock. This represents a 84.2% upside from the current price of $8.69.
CryoPort (NASDAQ:CYRX) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating. They now have a $15.00 price target on the stock. This represents a 72.7% upside from the current price of $8.69.
Driven Brands (NASDAQ:DRVN) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $23.00 price target on the stock, up previously from $17.00. This represents a 33.3% upside from the current price of $17.25.
Edgewell Personal Care (NYSE:EPC) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $23.00 price target on the stock, down previously from $26.00. This represents a 7.2% upside from the current price of $21.46.
Flotek Industries (NYSE:FTK) was upgraded by analysts at Northland Securities from a “market perform” rating to an “outperform” rating. They now have a $16.00 price target on the stock. This represents a 26.2% upside from the current price of $12.68.
Grocery Outlet (NASDAQ:GO) was upgraded by analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating. They now have a $16.00 price target on the stock, up previously from $13.00. This represents a 4.4% downside from the current price of $16.73.
Grocery Outlet (NASDAQ:GO) was upgraded by analysts at Craig Hallum from a “hold” rating to a “buy” rating. They now have a $17.00 price target on the stock. This represents a 1.6% upside from the current price of $16.73.
Halozyme Therapeutics (NASDAQ:HALO) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $75.00 price target on the stock, up previously from $62.00. This represents a 17.6% upside from the current price of $63.77.
Hologic (NASDAQ:HOLX) was upgraded by analysts at Royal Bank Of Canada from a “sector perform” rating to an “outperform” rating. They now have a $87.00 price target on the stock. This represents a 28.4% upside from the current price of $67.75.
Incyte (NASDAQ:INCY) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $89.00 price target on the stock, up previously from $67.00. This represents a 15.0% upside from the current price of $77.37.
JBT Marel (NYSE:JBTM) was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating.The current price is $141.45.
CarMax (NYSE:KMX) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $58.00 price target on the stock, down previously from $65.00. This represents a 1.2% upside from the current price of $57.29.
Leidos (NYSE:LDOS) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $205.00 price target on the stock, up previously from $185.00. This represents a 18.5% upside from the current price of $172.95.
LeMaitre Vascular (NASDAQ:LMAT) was upgraded by analysts at Barrington Research from a “market perform” rating to an “outperform” rating. They now have a $95.00 price target on the stock. This represents a 1.1% upside from the current price of $93.96.
Ringcentral (NYSE:RNG) was upgraded by analysts at Oppenheimer Holdings, Inc. from a “market perform” rating to an “outperform” rating. They now have a $35.00 price target on the stock. This represents a 21.1% upside from the current price of $28.90.
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating. They now have a $460.00 price target on the stock. This represents a 21.1% upside from the current price of $379.88.
Time is Running Out to Consider These 7 Stocks (ad)
7 Cheap and Good Stocks to Buy Now 💰
Discover 7 massively discounted stocks ready for growth. This free report features companies like Stock #1, a niche AI leader in voice recognition technology, and Stock #6, an energy drink company rapidly expanding across major retailers.
CACI International (NYSE:CACI) was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $535.00 price target on the stock, down previously from $570.00. This represents a 15.2% upside from the current price of $464.42.
Coupang (NYSE:CPNG) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating. They now have a $27.00 price target on the stock. This represents a 2.4% downside from the current price of $27.65.
New Oriental Education & Technology Group (NYSE:EDU) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $50.00 price target on the stock, down previously from $58.00. This represents a 8.4% upside from the current price of $46.12.
The Coin That Could Define Trump’s Crypto Presidency (ad)
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Adagene (NASDAQ:ADAG) is now covered by analysts at Leerink Partners. They set an “outperform” rating and a $7.00 price target on the stock. This represents a 242.3% upside from the current price of $2.05.
BlackLine (NASDAQ:BL) is now covered by analysts at DA Davidson. They set a “neutral” rating and a $56.00 price target on the stock. This represents a 5.2% upside from the current price of $53.24.
Indivior (NASDAQ:INDV) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $27.00 price target on the stock. This represents a 23.3% upside from the current price of $21.89.
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $31.00 price target on the stock. This represents a 103.9% upside from the current price of $15.20.
Xilio Therapeutics (NASDAQ:XLO) is now covered by analysts at Leerink Partners. They set an “outperform” rating and a $2.00 price target on the stock. This represents a 197.2% upside from the current price of $0.67.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.